Jack Benrube

Delusional sports fanatic of disastrous teams. I possess an extremely educated pallet.

[Jack Benrube @JBenrube]

@Hightop_Dave I absolutely love this by everyone. Miami is hated again, we are making real progress.

[Jack Benrube @JBenrube]

@marlbororedddss Yes we need more of this. When people are speaking like this, I know we are back

[Jack Benrube @JBenrube]

@_joshpray Settle down Josh

[Jack Benrube @JBenrube]

@TJSalomone I love this, this is exactly what existed in the 80’s and 90’s. TJ keep pumping brother

[Jack Benrube @JBenrube]

@ryanpduffy I don’t think anyone cares what you think. The results shows a win next to their name lol. Putz

[Jack Benrube @JBenrube]

@MalikZaire8 And you guys couldn’t take care of business

[Jack Benrube @JBenrube]

@krassenstein @davidjollyfl What? I was there and I didn’t hear a single boo.

[Jack Benrube @JBenrube]

@ClemsonCarl Hahahahahahaa this has to be satire

[Jack Benrube @JBenrube]

@RealCandaceO Who are these losers?

[Jack Benrube @JBenrube]

@krassenstein You are such a loser man, who cares

[Jack Benrube @JBenrube]

@_joshpray Correct.

[Marty Chargin @MartyChargin]

$FBRX ... Forte Biosciences: argenx to acquire Forte Biosciences for $2.2 bln (54.78)
argenx (ARGX) agreed to acquire Forte Biosciences for $77 per share in cash, valuing the company at approximately $2.2 bln. The transaction is expected to close in Q3 2026, subject to customary closing conditions.
The acquisition adds FB102, a first-in-class anti-CD122 antibody, to argenx's immunology pipeline. The therapy has shown positive Phase Ib results in vitiligo and celiac disease and has potential applications in additional autoimmune diseases.
The $77 per share offer represents an 86% premium to Forte's volume-weighted average share price since the company reported positive Phase Ib vitiligo data on July 9.
argenx said the acquisition will be funded entirely with cash on hand, is not subject to a financing condition, and expands its immunology portfolio with a differentiated approach targeting pathogenic T-cell and NK-cell activity.

[Jack Benrube @JBenrube]

@TheSaviour What a total putz you are lol

[Jack Benrube @JBenrube]

@cperruna @padraig5762 It appears Mike is a putz with that comment.

[Jack Benrube @JBenrube]

@DavidFurones_ Mark Duper

[Jack Benrube @JBenrube]

@hodgetwins The face of success, unlike you two buffoons

[Jack Benrube @JBenrube]

@FloraLuzz_ Nice!

[Jack Benrube @JBenrube]

@PaulRieckhoff This might win the most retarded take of the year. Total putz

[Jack Benrube @JBenrube]

@RitaPanahi lol

[Jack Benrube @JBenrube]

@HustleBitch_ Peptides and hair dye, it’s that easy